Searchable abstracts of presentations at key conferences on calcified tissues

ba0004p176 | (1) | ICCBH2015

Evaluation of fibroblast growth factor 23 in patients with hypophosphataemic rickets

Park Julie , Khan Kursheed , Hatchard Lynne , Ramakrishnan Renuka , Senniappan Senthil , Fraser William , Dharmaraj Poonam

Objective: Hypophosphataemic rickets (HPR) is associated with high concentrations of fibroblast growth factor 23 (FGF23). Chronically elevated FGF23 may impact on cardiac function and the skeleton. There is little evidence on how FGF23 changes with time in HPR or how it is affected by treatment. The aim of this study was to evaluate changes in FGF23 concentrations over time in patients with HPR.Methods: Retrospective data was collected from our Metabolic...

ba0006p126 | (1) | ICCBH2017

A case of severe reaction following the use of Bisphosphonates in a patient with Osteogenesis Imperfecta

Park Julie , Alsaffar Hussain , Apperley Louise , Bishop Nick , Dharmaraj Poonam , Ramakrishnan Renuka

Background: We present a case of unusual delayed multi-systemic reaction, following treatment with Pamidronate. The reaction, resembling rhabdomyolysis, requiring intensive care support, has not been reported previously to our knowledge.Presenting problem: An 11 month old boy with severe osteogenesis imperfecta (OI) presented with hyperpyrexia and respiratory distress 10 days after his fifth cycle of Pamidronate. He had significant derangement of his bio...

ba0005p112 | Cancer and bone: basic, translational and clinical | ECTS2016

Myeloid-derived suppressor cells (MDSC) mediate the positive feedback loop of prostate tumor-bone interactions

Park Serk in

Advanced-stage prostate and breast cancer patients commonly develop bone metastases, accounting for significant clinical problems such as pain, fracture, immobility and death. Bone is comprised of diverse cell types that are potentially involved in metastatic progression. However, how cancer cells interact with these cells within the bone microenvironment to support their expansion and activity remains unclear. Recent data from our laboratory highlighted a novel feed-forward m...

ba0002p133 | (1) | ICCBH2013

Linear growth over 2 years of velaglucerase alfa therapy in children with type 1 Gaucher disease previously treated with imiglucerase

Zimran Ari , Hughes Derralynn , Elstein Deborah , Smith Laurie , Harmatz Paul , Rhead William , Giraldo Pilar , Mendelsohn Nancy , Park Chan-Hoo , Zahrieh David , Crombez Eric

Objectives: As children with confirmed type 1 Gaucher disease (inherited metabolic disorder) may have linear growth retardation, we evaluated linear growth over 2 years in children enrolled in the interventional study TKT034, in which patients receiving imiglucerase enzyme replacement therapy were switched to velaglucerase alfa.Methods: Trial TKT034 enrolled patients who were ≥2 years of age with type 1 Gaucher disease and stable clinical parameter...

ba0005p138 | Cell biology: osteoblasts and bone formation | ECTS2016

Osteoblastogenesis is regulated through the interplay between human arrest defective 1 and runt-related transcription factor 2

Park Jong-Wan

Arrest defective 1 was originally identified as an acetyltransferase essential for the life-cycle progression in yeasts. Its human orthologue hARD1 has been known to express the enzymatic activity and to acetylate several targets such as HIF-1alpha, MLCK-1, and beta-catenin. Here, whether hARD1 takes part in pre-osteoblast differentiation toward calcium-deposing osteoblast was explored. ALP staining and alizalin red S staining showed that osteoblast differentiation was negativ...

ba0005p383 | Osteoporosis: treatment | ECTS2016

A interventional study in a real life setting to assess the clinical efficacy and effect to fracture in the 1 year after the injection of zoledronic acid in osteoporotic patients with long bone or spine, pelvic fractures

Lee Jaewon , Kim Joonguk , Park Ki-chul , Park Ye-Soo

Objectives: There are some studies that evaluated changes of bone marrow density (BMD) and re-fracture after zoledronic acid injection. However, there is no study that showed about the fracture on all of the body, fracture healing, and improvement of clinical symptom after zoledronic acid injection. In this study, authors evaluated the 1 year BMD change, changes of lumbar pain in lumbar spine fractures, effects on fracture healing, re-fracture and additional fracture on other ...

ba0001pp297 | Muscle, physical activity and bone | ECTS2013

Prevalence of sarcopenia and its association with osteporosis in Korean postmenopausal women

Park Hyoung-Moo , Kim Tak

Introduction: Advancing age is associated with decline in bone and muscle mass and quality. Sarcopenia, one of Geriatric syndromes, is defined as the age-associated loss of skeletal muscle mass and function resulting in disability, poor QOL and death.Objective: To evaluate the prevalence of sarcopenia and its association with osteopenia/osteoporosis in Korean PMW.Materials and methods: Subjects: total 225 Korean PMW over 50 years w...

ba0005p330 | Osteoporosis: pathophysiology and epidemiology | ECTS2016

Regression analysis between multiple osteoporotic spine fracture and osteoporotic fracture risk factors

Lee Jaewon , Park Ye-Soo

Objectives: There are some studies that evaluated changes of bone marrow density (BMD) and re-fracture after zoledronic acid injection. However, there is no study that showed about the fracture on all of the body, fracture healing, and improvement of clinical symptom after zoledronic acid injection. In this study, authors evaluated the 1-year BMD change, changes of lumbar pain in lumbar spine fractures, effects on fracture healing, re-fracture and additional fracture on other ...

ba0003pp40 | Bone development/growth and fracture repair | ECTS2014

NFI-C regulates osteoblast differentiation via control of osterix expression

Park Joo-Cheol , Lee Dong-Seol

In bone marrow, bone marrow stromal cells (BMSCs) have the capacity to differentiate into osteoblasts and adipocytes. Onset of osteoporosis with age stems in part from the enhanced bone marrow adipogenesis that represses osteogenesis. In this study, we demonstrate that disruption of nuclear factor I-C (NFI-C) impairs osteoblast differentiation and bone formation, and increases bone marrow adipocytes. Interestingly, NFI-C controls postnatal bone formation but does not influence...

ba0003pp102 | Cancer and bone: basic, translational and clinical | ECTS2014

Paget's sarcoma -- A case report in Korea

Park Yong-Koo , Lee Geon Kook

Paget’s disease of bone is a condition where the process of bone remodeling is disrupted; Its primary event is an increased bone resorption followed by a subsequent reactive bone formation. The disease is most common in central Europe, the United Kingdom, Australia, and New Zealand. It is also found, though with lower incidence, in southern Europe, Scandinavia, and the United States. It is extremely rare in East Asian countries, especially in Korea, Japan, China, the Midd...